IFM Tre

Novartis Adds Inflammation Drugs to Pipeline with Deal for IFM Tre
Xconomy
Mon, 04/1/19 - 10:31 am
Novartis
IFM Tre
M&A
anti-inflammatory
inflammation
Fresh Off Bristol Buyout, IFM Backers Raise $31M to Plot a Second Strike
Xconomy
Thu, 07/19/18 - 09:54 am
IFM Therapeutics
Bristol-Myers Squibb
IFM Tre